Clinical Trial Update: Efficacy of Atenativ in Patients With Congenital Antithrombin Deficiency Undergoing Surgery or Delivery [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Atenativ for efficacy in patients with congenital antithrombin deficiency undergoing surgery or delivery; the study is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Antithrombin Deficiency

Drugs mentioned

• Atenativ

Snippet

Sponsor: Octapharma | Conditions: Congenital Antithrombin Deficiency | Phase 3 | Status: RECRUITING